Ditchcarbon
  • Contact
  1. Organizations
  2. Dyne Therapeutics, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 14 days ago

Dyne Therapeutics, Inc.

Company website

Dyne Therapeutics, Inc., a pioneering biotechnology company headquartered in the United States, focuses on developing innovative therapies for serious muscle diseases. Founded in 2017, Dyne has quickly established itself in the biopharmaceutical industry, particularly in the realm of gene therapy and muscle-targeted drug development. The company’s core offerings include its proprietary FORCE™ platform, which enables the creation of targeted therapies that address the underlying causes of muscle disorders. This unique approach positions Dyne Therapeutics as a leader in the market, with a commitment to transforming the lives of patients suffering from debilitating conditions. With significant advancements in its research and development pipeline, Dyne Therapeutics continues to make notable strides, solidifying its reputation as a key player in the biotechnology sector.

DitchCarbon Score

How does Dyne Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

32

Industry Benchmark

Dyne Therapeutics, Inc.'s score of 25 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

42%

Let us know if this data was useful to you

Dyne Therapeutics, Inc.'s reported carbon emissions

Dyne Therapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Dyne Therapeutics may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the biopharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Dyne Therapeutics to establish clear climate commitments and reduction initiatives. This could include setting science-based targets for emissions reductions, engaging in renewable energy initiatives, or participating in industry-wide climate pledges. Without such commitments, the company may face challenges in aligning with broader environmental goals and expectations from stakeholders.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Dyne Therapeutics, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Dyne Therapeutics, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Dyne Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

DTx Pharma, Inc.

US
•
Health and social work services (85)
Updated 1 day ago

RNA

DE
•
Fabricated metal products, except machinery and equipment (28)
Updated 12 days ago

Roche Innovation Center Copenhagen A/S

DK
•
Research and development services (73)
Updated 24 days ago

ABUS

DE
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Ionis Pharmaceuticals

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Wave Life Sciences Ltd.

SG
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251008.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy